DMD: pharmacology trials-1

  • WAVE Dystance: A Randomized, Double-blind, Placebo-controlled, Efficacy and Safety Study of WVE-210201 in Ambulatory Patients with Duchenne Muscular Dystrophy
  • WAVE-OLE: A Multicenter, Open-Label Extension Study of WVE-210201 in Patients previously enrolled in WVE-DMDX51-001

Acronym

WAVE Dystance

WAVE-OLE

Study type BMR BMR
Trial type Multicentre trial Multicentre trial
Intervention WVE-210201 WVE-210201
Principal investigator Odile Boespflug-Tanguy Odile Boespflug-Tanguy
Sponsor WAVE WAVE
Study status Ongoing Ongoing
Recruitment status Ongoing Ongoing
Population Child Child